$IVZ

Invesco Ltd Stock 12‑Month Price Target Raised to $31.92, Implies 6% Upside

Analyst estimates cited by FactSet show Invesco Ltd’s average 12-month price target increased to $31.92 from $31.58. The range is $28 to $37, implying about 6% upside versus the Jul. 27 close. The consensus rating remains “Buy” with 5 Buys, 10 Holds, and 0 Sells.

Original reporting
Published Jul 28, 2026, 10:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Invesco Ltd Stock 12‑Month Price Target Raised to $31.92, Implies 6% Upside — source image
Decision brief

The 30-second read

$IVZBullishLow
01

Why it matters

Consensus target increased to $31.92 (from $31.58), with forecasts spanning $28 to $37, while the overall rating remains “Buy.”

02

Market read

Traders may treat this as a mild sentiment input, but it lacks a new fundamental driver.

03

What to watch

The article does not specify which analysts changed targets, the magnitude of individual revisions, or any updated earnings/guidance assumptions behind the new $31.92 consensus.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day analyst consensus update (published 2026-07-28)

Background

The piece summarizes FactSet-based analyst consensus: average 12-month target, range, and rating distribution.

Company-level read

Ticker impact

$IVZBullishMedium confidence
Context

Article says Invesco’s average 12-month price target rose from $31.58 to $31.92, implying about 6% upside from the Jul. 27 close.

Expected impact

Likely limited, sentiment-driven effect; any price reaction should fade unless accompanied by new earnings, guidance, or analyst thesis changes.

Evidence & confidence

The only disclosed change is the consensus target and implied upside, with rating still “Buy” (5 Buys, 10 Holds, 0 Sells). No new company-specific catalyst is provided.

Market effects

Minimal. Analyst target revisions for an asset manager can slightly influence sector sentiment, but no sector-wide catalyst is cited.

None indicated.

None indicated.

Counterpoint

A higher average target can reflect methodology or peer revisions rather than new Invesco fundamentals, so the market may not re-rate meaningfully.

Key entities

  • Invesco Ltd

    Asset manager whose consensus 12-month price target and implied upside were updated.

Related articles

$IVZMed

Invesco Ltd. Q2 2026 Earnings Call Summary

Invesco reported Q2 2026 record net long-term inflows of $45.1B and operating margin of 37.5%, citing 17% year-to-date net revenue growth. Management said 30+ products drove over $500M in net inflows, with QQQ contributing $130M incremental net revenue in H1. It targets high-30s operating margin, a 60% payout ratio, and notes $15M quarterly one-time platform costs.

$IVZMed

Invesco (NYSE:IVZ) Surprises With Strong Q2 CY2026

Invesco (NYSE:IVZ) reported Q2 CY2026 results that beat expectations. Revenue rose 65.3% year over year to $1.83 billion, exceeding Wall Street estimates by 37%. Non-GAAP EPS was $0.71, 7.2% above consensus. Assets under management were $2.47 trillion, up 23.4% year over year, and the stock was about $30.37 after the release.